ACSM3, as one member of the acyl-CoA synthetase medium-chain family, was found to be frequently down-regulated in HCC patients exhibiting high AFP levels, high ALT levels, large tumors, and multiple nodules. Here, AFP is linked to hepatocellular carcinoma.